Skip to main content
Fig. 2 | BMC Medicine

Fig. 2

From: PCDHGB7 hypermethylation-based Cervical cancer Methylation (CerMe) detection for the triage of high-risk human papillomavirus-positive women: a prospective cohort study

Fig. 2

CerMe detection as a triage strategy for hrHPV-positive women. A The distribution of HPV16/18 and other 12 hrHPV types in hrHPV-positive women. B The proportion of colposcopic pathology in HPV16/18 and other 12 hrHPV type-positive women. C Cytology testing as a triage for other 12 hrHPV type-positive women. D Cytology testing as a triage for HPV16/18-positive women. E CerMe detection as a triage for other 12 hrHPV type-positive women. F CerMe detection as a triage for HPV16/18-positive women. G The performance of other 12 hrHPV type-positive women triaged by cytology testing or CerMe detection. H The performance of HPV16/18 type-positive women triaged by cytology testing or CerMe detection

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us